Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 145 publications
A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 14, 2026
Long-Term Storage of Formalin-Fixed Paraffin-Embedded Tissues Negatively Impacts Next-Generation Sequencing: Successful Restoration with a DNA Repair Enzyme.
Journal: Clinical chemistry
Published: February 27, 2026
A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.
Journal: medRxiv : the preprint server for health sciences
Published: February 23, 2026
Lymphoid malignancy and clonality in the POT1-mediated long telomere syndrome.
Journal: Blood
Published: August 26, 2025
Lenalidomide-associated reversible TP53-mutated clonal hematopoiesis in plasma cell neoplasms.
Journal: Haematologica
Published: July 10, 2025
Full-Length Clonal Immunoglobulin Rearrangements in cfDNA: Improved Recovery and Sequencing.
Journal: Clinical chemistry
Published: December 10, 2024
Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion.
Journal: JCO precision oncology
Published: October 11, 2024
Brain Metastasis in Pediatric Patients with Osteosarcoma.
Journal: Current oncology (Toronto, Ont.)
Published: September 30, 2024
Diagnostic and Prognostic/Therapeutic Significance of Comprehensive Analysis of Bone and Soft Tissue Tumors Using Optical Genome Mapping and Next-Generation Sequencing.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 23, 2024
ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors.
Journal: Acta neuropathologica
Published: June 25, 2024
1q jumping translocation as a biomarker in myeloid malignancy: frequently mutated genes associated with bad prognosis and low survival.
Journal: Experimental hematology & oncology
Published: June 11, 2024
Last Updated: 09/26/2026